ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLC.

Santa-Catalina PG, Posado-Domínguez L, López-Gutiérrez Á, Del Barco Morillo E, Redondo-González JC, Egido-Iglesias N, Corvo-Félix L, Muela Bravo I, Rodrigues-Françoso A, Bellido-Hernández L, Fonseca-Sánchez E, Cruz-Hernández JJ, Corchado JM, García Hernández JL, Olivares-Hernández A.

Open source

DOI: 10.3389/fonc.2026.1876274
Published: 2026-07-31
Container: Front Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1876274,
  title = {ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLC.},
  author = {Santa-Catalina PG and  Posado-Domínguez L and  López-Gutiérrez Á and  Del Barco Morillo E and  Redondo-González JC and  Egido-Iglesias N and  Corvo-Félix L and  Muela Bravo I and  Rodrigues-Françoso A and  Bellido-Hernández L and  Fonseca-Sánchez E and  Cruz-Hernández JJ and  Corchado JM and  García Hernández JL and  Olivares-Hernández A.},
  year = {2026},
  journal = {Front Oncol},
  doi = {10.3389/fonc.2026.1876274},
  url = {https://doi.org/10.3389/fonc.2026.1876274}
}

RIS

TY  - JOUR
TI  - ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLC.
AU  - Santa-Catalina PG
AU  -  Posado-Domínguez L
AU  -  López-Gutiérrez Á
AU  -  Del Barco Morillo E
AU  -  Redondo-González JC
AU  -  Egido-Iglesias N
AU  -  Corvo-Félix L
AU  -  Muela Bravo I
AU  -  Rodrigues-Françoso A
AU  -  Bellido-Hernández L
AU  -  Fonseca-Sánchez E
AU  -  Cruz-Hernández JJ
AU  -  Corchado JM
AU  -  García Hernández JL
AU  -  Olivares-Hernández A.
PY  - 2026
JO  - Front Oncol
DO  - 10.3389/fonc.2026.1876274
UR  - https://doi.org/10.3389/fonc.2026.1876274
ER  -

APA

PG, S., L, P., Á, L., E, D. B. M., JC, R., N, E., L, C., I, M. B., A, R., L, B., E, F., JJ, C., JM, C., JL, G. H., & A., O. (2026). ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLC.. Front Oncol. https://doi.org/10.3389/fonc.2026.1876274

Source records

europe-pmc · retrieved 2026-09-25T19:50:48.003Z
doaj · retrieved 2026-09-25T19:50:48.007Z